Search for stocks /

Punjab Chemicals Q3 FY26: ₹247 Cr Revenue, 153% Profit Jump… But Is This a Comeback or Just a Chemical Illusion?


1. At a Glance – The Great Indian Chemical Thriller

Picture this: a 50-year-old chemical company quietly sitting in Punjab suddenly wakes up and delivers 153% YoY profit growth. Investors blink. Analysts refresh Excel. And somewhere in China, a chemical trader sneezes and global prices shift again.

Welcome to Punjab Chemicals & Crop Protection Ltd, a company that lives in the most dramatic industry ever — agrochemicals — where your profits depend on monsoon, China, farmers’ mood, and sometimes even politics.

In Q3 FY26, the company reported:

  • Revenue: ₹247 Cr
  • PAT: ₹14 Cr
  • EPS: ₹11.26
  • Margins improving despite fuel cost pressure

Sounds impressive? Yes.

But wait.

This is also a company where:

  • Top 5 customers = ~68% revenue (basically, if 2 clients ghost them, it’s emotional damage)
  • Export markets are still shaky
  • Margins depend heavily on product mix, not pricing power

So the big question is:
👉 Is this a structural turnaround… or just a temporary spike driven by product mix?

Let’s put on our detective hat and investigate.


2. Introduction – Chemical Business or Mood Swing Simulator?

Punjab Chemicals is not your typical FMCG or IT darling.

This is a company where:

  • Demand depends on crop cycles
  • Prices depend on China dumping inventory
  • Margins depend on raw material volatility

Basically, this business is like Indian cricket:
👉 Unpredictable, emotional, and occasionally brilliant.

Now here’s the interesting twist.

Management is actively trying to escape the commodity trap by:

  • Moving into CRAMS (Contract manufacturing)
  • Adding complex chemistry capabilities
  • Launching new high-margin products

Sounds great on paper.

But the execution? That’s where things get spicy.

Because:

  • New products take 2–3 years to scale
  • Contracts take 6–9 months just to finalize
  • And revenue ramp is slow and painful

So the real game here is patience.

Let me ask you:
👉 Do you like businesses that reward patience… or ones that test your sanity?


3. Business Model – WTF Do They Even Do?

Let’s simplify this chemical maze.

Punjab Chemicals operates in 3 main segments:

1. Agrochemicals (The Bread & Butter)

  • Herbicides, fungicides, insecticides
  • Works with giants like UPL, Bayer, BASF
  • Also does CRAMS (contract manufacturing)

👉 Translation:
They don’t just sell chemicals… they make chemicals for other companies who sell them at higher prices.

Classic outsourcing play.


2. Performance & Specialty Chemicals

  • Complex multi-step chemistry
  • Used in pharma intermediates and APIs

👉 This is where the money is.

High entry barrier = higher margins.


3. Industrial Chemicals

  • Phosphorous-based products
  • Lower margin, more volume-driven

👉 Basically the “ghar ka ration” segment — stable but boring.


Real Strategy (Hidden Between the Lines)

Management clearly said:

  • Moving away from commodity products
  • Focusing on value-added chemistry
  • Building new capabilities like hydrogenation & mercaptan chemistry

This is crucial.

Because:
👉 Commodity chemicals = price war
👉 Specialty chemicals = pricing power

So the company is trying to go from:

“Sabzi mandi seller” → “Fine dining chef”

But will they succeed?


4. Financials Overview – Numbers Don’t Lie (But They Do Flirt)

Quarterly Performance (₹ Crores)

MetricDec 2025Dec 2024Sep 2025YoY %QoQ %
Revenue247214255+15.3%-3%
EBITDA301926+58%+15%
PAT14619+153%-26%
EPS (₹)11.264.9515.12+127%-25%

EPS Calculation (Quarterly Results Detected ✅)

  • Q3 EPS = ₹11.26
  • Annualised EPS = 11.26 × 4 = ₹45.04

Observations (Auditor Mode ON)

  • Revenue growth decent but not explosive
  • Profit growth = INSANE (153%)
  • QoQ profit drop → momentum not consistent

👉 Translation:

Company is improving, but still volatile.

Let me ask:
👉 Would you trust a company where profits swing this much every quarter?


5. Valuation Discussion – Is It Cheap or Just Looks Cheap?

Current Data

  • CMP: ₹893
  • Annualised EPS: ₹45.04
  • P/E: ~19.8

1. P/E Valuation

Industry P/E ≈ 19

Fair Value Range:

  • Lower: ₹45 × 15 = ₹675
  • Upper: ₹45 × 22 = ₹990

2. EV/EBITDA

  • EV = ₹1,192 Cr
  • EBITDA (TTM approx) ≈ ₹116 Cr

EV/EBITDA ≈ 10

Fair Range:

  • 8× → ₹900 Cr
  • 12× → ₹1,392 Cr

3. DCF (Simplified)

Assumptions:

  • Growth: 10–12%
  • Margin improvement to 13–15%

Fair Range:
👉 ₹700 – ₹1,050


Final Fair Value Range:

👉 ₹700 – ₹1,050

⚠️ This fair value range is for educational

Join 10,000+ investors who read this every week.
Become a member
error: Content is protected !!